reference/28271379

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28271379

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural
issn	1471-2407
issueIdentifier	1
pageRange	243-
publicationName	BMC Cancer
startingPage	243
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2fffe449810426ea069a6a41285d99d8 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c6c2798deab8db3dce593f647cb7cc06 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_35939ca0f498c00a1094ad911318265e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b48963e9ea6b5c93fdf2bad6d96a1c84 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ab80a732b5df33e85751c0a758afb577
bibliographicCitation	Xu J, Shetty PB, Feng W, Chenault C, Bast RC, Issa JP, Hilsenbeck SG, Yu Y. Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome. BMC Cancer. 2012 Jun 13;12():243. PMID: 22695491; PMCID: PMC3476972.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6876ba7877b44a64e26d77a3c42f6c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80069068acf652f9a7073dd1ee6a7749 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9f035cae8bbd199e54f1e6cde011e17 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0131a004305e43ee78e3997ca596cca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f4b12d9dcf0ce6f254f5af8a2089da0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_051274c86925f4ab26aef729a7c1f2c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa86bbd0b9b8f4ff5097375d76866d33 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3447c5d883e300fde5133f0cdb70a49e http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0254-6261
date	2012-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/22695491 https://pubmed.ncbi.nlm.nih.gov/PMC3476972 https://doi.org/10.1186/1471-2407-12-243
isPartOf	https://portal.issn.org/resource/ISSN/1471-2407 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome
discusses	http://id.nlm.nih.gov/mesh/M0367550 http://id.nlm.nih.gov/mesh/M0024234 http://id.nlm.nih.gov/mesh/M0374857 http://id.nlm.nih.gov/mesh/M0018613 http://id.nlm.nih.gov/mesh/M0262287 http://id.nlm.nih.gov/mesh/M0006678 http://id.nlm.nih.gov/mesh/M0554498 http://id.nlm.nih.gov/mesh/M0462460 http://id.nlm.nih.gov/mesh/M0024747 http://id.nlm.nih.gov/mesh/M0398382 http://id.nlm.nih.gov/mesh/M0018586 http://id.nlm.nih.gov/mesh/M0028048
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6d00df506eed78175933b5ecde287c64 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6903bae4d722fdfcea22bb6a83b8e2e1 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0e8c6430377a3b9d92d08cd863bb38df http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b6f3ed43d6c872c60676fec4bb28ff75 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11186 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8572 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129138006 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1012 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID92304

Total number of triples: 59.